Anteris Technologies Global vs Picard Medical
AVR and PMI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVR and PMI compare
Anteris Technologies Global is the larger company, worth 32 times as much as Picard Medical ($518M against $16.2M).
Picard Medical grew revenue faster over the last twelve months (11.6% versus 9.0% for Anteris Technologies Global).
Picard Medical keeps more of each dollar of sales as profit, with a net margin of −371% compared with −4637% at Anteris Technologies Global.
Picard Medical scores higher on the StockData Score (6 against 5 for Anteris Technologies Global), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVR | PMI |
|---|---|---|
| Size and price | ||
| Market cap | $518M | $16.2M |
| Share price | $5.32 | $6.91 |
| Change, 1 year | 44.2% | −94.9% |
| Beta (5Y) | 1.67 | −2.18 |
| Employees | 174 | 75 |
| StockData Score | ||
| Total score | 5 | 6 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 3 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 222× | 3.0× (better) |
| P/B | 2.3× (better) | 12.2× |
| FCF yield | −18.0% | – |
| Fair value | – | $3.92 |
| Margin of safety | – | −76.5% |
| Growth | ||
| Revenue growth (TTM) | 9.0% | 11.6% (better) |
| Profitability | ||
| Gross margin | 75.8% (better) | 26.2% |
| Operating margin | −4880% | −267% (better) |
| Net margin | −4637% | −371% (better) |
| FCF margin | −4008% | – |
| Return on equity | −93.8% (better) | −426% |
| Return on invested capital | −3856% | −351% (better) |
| Financial health | ||
| Debt / equity | 0.00 (better) | 0.00 |
| Interest coverage | −615.2× | – |
| Current ratio | 12.45 (better) | 0.99 |
| Altman Z-score | 5.96 (better) | −17.62 |
| Piotroski F-score | 1 | 5 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 0.00% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 70.8% | 6.5% |
| Held by insiders | 32.6% | – |
| Insider net buying, 12 months | $44.1M | – |
| Short interest, % of float | 13.8% | – |
Go deeper
- AVR stock overview
- AVR income statement
- AVR valuation and score
- PMI stock overview
- PMI income statement
- PMI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.